Pancreatic Cancer Cell Genetics and Signaling Response to Treatment Correlate with Efficacy of Gemcitabine-Based Molecular Targeting Strategies

被引：0
|
作者：
Bryan Holcomb
Michele T. Yip-Schneider
Jesus M. Matos
Jennifer Dixon
Jason Kennard
Julie Mahomed
Rajasubramaniam Shanmugam
Judith Sebolt-Leopold
C. Max Schmidt
机构：
[1] Indiana University School of Medicine,Department of Surgery
[2] Indiana University School of Medicine,Departments of Biochemistry/Molecular Biology
[3] Indiana University School of Medicine,Walther Oncology Center
[4] Indiana University Cancer Center,Department of Hematology and Oncology
[5] Richard L. Roudebush VA Medical Center,undefined
[6] Indiana University School of Medicine,undefined
[7] Pfizer,undefined
[8] Inc.,undefined
来源：
Journal of Gastrointestinal Surgery | 2008年 / 12卷
关键词：
Pancreatic cancer; NF-κB; PI3 kinase; MAP kinase; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：288 / 296
页数：8
相关论文
共 50 条
  • [41] Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
    Tarannum, Mubin
    Vivero-Escoto, Juan L.
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 187
  • [42] A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
    Chapa-Gonzalez, Christian
    Lopez, Karina
    Michelle Lomeli, Kimberly
    Alberto Roacho-Perez, Jorge
    Stevens, Jazmin Cristina
    LIFE-BASEL, 2022, 12 (03):
  • [43] Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model
    Jenner, Adrianne L. L.
    Kelly, Wayne
    Dallaston, Michael
    Araujo, Robyn
    Parfitt, Isobelle
    Steinitz, Dominic
    Pooladvand, Pantea
    Kim, Peter S. S.
    Wade, Samantha J. J.
    Vine, Kara L. L.
    PLOS COMPUTATIONAL BIOLOGY, 2023, 19 (01)
  • [44] Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
    Miki, Masami
    Fujimori, Nao
    Ueda, Keijiro
    Lee, Lingaku
    Murakami, Masatoshi
    Takamatsu, Yu
    Shimokawa, Yuzo
    Niina, Yusuke
    Oono, Takamasa
    Hisano, Terumasa
    Furukawa, Masayuki
    Ogawa, Yoshihiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [45] RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report
    Chuan Zeng
    Weidong Fan
    Xianquan Zhang
    Cellular Oncology, 2015, 38 : 319 - 325
  • [46] ROBUSTNESS OF OUTCOMES IN INDIRECT COMPARISON METHODS OF PEGYLATED LIPOSOMAL IRINOTECAN FOR THE TREATMENT OF METASTATIC PANCREATIC CANCER IN PATIENTS WHO HAVE PROGRESSED FOLLOWING GEMCITABINE-BASED THERAPY
    Felix, Parreia J.
    Andreozzi, V
    Henriques, J.
    Amorim, A. P.
    Massetti, M.
    VALUE IN HEALTH, 2024, 27 (12) : S360 - S360
  • [47] KRAS mutation in cell-free DNA was correlated with treatment response to gemcitabine/cisplatin chemotherapy in patients with pancreatic cancer
    Kim, Min Kyeong
    Kyong-Ah, Yoon
    Myung, Woo Sang
    Hee, Kim Yun
    Jae, Park Sang
    -Young, Kong Sun
    CANCER RESEARCH, 2016, 76
  • [48] Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab
    Pant, Shubham
    Martin, Ludmila K.
    Geyer, Susan
    Wei, Lai
    Van Loon, Katherine
    Sommovilla, Nili
    Zalupski, Mark
    Iyer, Renuka
    Fogelman, David
    Ko, Andrew H.
    Bekaii-Saab, Tanios
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (06): : 614 - 618
  • [49] The addition of S-1 to gemcitabine-based chemotherapy improves survival with increased toxicity for patients with advanced pancreatic cancer: Combined meta-analysis of efficacy and safety profile
    Liu, Yang
    Huang, Qing-ke
    Hong, Wan-dong
    Wu, Jin-ming
    Sun, Xue-cheng
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (02) : 254 - 260
  • [50] Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis
    Guo, Sitong
    Li, Yan
    Su, Henghai
    Meng, Mingyu
    Xi, Jiaxi
    Mo, Guangyan
    Chen, Xiaoyu
    PHARMACEUTICAL BIOLOGY, 2021, 59 (01) : 1260 - 1275
12345